...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Idea for Zenith
Reply New Message
Prev Message Back To Forum Threaded View Next Message

On a separate thought Don is not allowing liquidity and backed off on the NASDAQ listing promises he made years ago.

Good thing considering where we are.  Don always said NASDAQ would have to be tied to major events.  It would cost us a ton of dilution and wouldn't improve the stock price IMO. There's decent liquidity with ZHCLF given where we are with news and events. 

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply